Education
About Us
Working with TipRanks
Follow Us
Medpace Holdings (MEDP)
NASDAQ:MEDP
Total Valuation
Medpace Holdings has a market cap or net worth of $9.00B. The enterprise value is $10.07B.
Market Cap$9.00B
Enterprise Value$10.07B
Share Statistics
Medpace Holdings has 30.23M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding30.23M
Owened by Insiders19.36%
Owened by Instutions28.26%
Financial Efficiency
Medpace Holdings’s return on equity (ROE) is 0.49 and return on invested capital (ROIC) is 38.11%.
Return on Equity (ROE)48.98%
Return on Assets (ROA)19.25%
Return on Invested Capital (ROIC)38.11%
Return on Capital Employed (ROCE)44.85%
Revenue Per Employee$357,466.78
Profits Per Employee$68,532.373
Employee Count5,900
Asset Turnover1.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Medpace Holdings is 25.43. Medpace Holdings’s PEG ratio is 0.61.
PE Ratio25.43
PS Ratio4.88
PB Ratio12.46
Price to Fair Value12.46
Price to FCF16.89
Price to Operating Cash Flow16.89
PEG Ratio0.61
Income Statement
In the last 12 months, Medpace Holdings had revenue of $2.11B and earned $404.34M in profits. Earnings per share was $13.06.
Revenue$2.11B
Gross Profit$649.07M
Operating Income$446.87M
Pretax Income$475.92M
Net Income$404.34M
EBITDA475.12M
Earnings Per Share (EPS)13.06
Cash Flow
In the last 12 months, operating cash flow was $608.82M and capital expenditures -$36.55M, giving a free cash flow of $572.27M billion.
Operating Cash Flow$608.82M
Free Cash Flow$572.27M
Free Cash Flow per Share$18.93
Dividends & Yields
Medpace Holdings pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield5.92%
Earnings Yield3.93%
Stock Price Statistics
Beta1.20
52-Week Price Change-23.10%
50-Day Moving Average325.96
200-Day Moving Average350.46
Relative Strength Index (RSI)31.54
Average Volume (3m)489.81K
Important Dates
Medpace Holdings upcoming earnings date is Apr 21, 2025, After Close.
Last Earnings DateFeb 10, 2025
Next Earnings DateApr 21, 2025
Ex-Dividend Date―
Financial Position
Medpace Holdings as a current ratio of 0.93, with Debt / Equity ratio of 0.15
Current Ratio0.93
Quick Ratio0.93
Debt to Market Cap0.01
Net Debt to EBITDA-1.22
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Medpace Holdings has paid $71.54M in taxes.
Income Tax$71.54M
Effective Tax Rate15.03%
Enterprise Valuation
Medpace Holdings EV to EBITDA ratio is 21.80, with an EV/FCF ratio of 16.00.
EV to Sales4.62
EV to EBITDA21.80
EV to Free Cash Flow16.00
EV to Operating Cash Flow16.00
Balance Sheet
Medpace Holdings has $669.44M in cash and marketable securities with $126.23M in debt, giving a net cash position of -$543.20M billion.
Cash & Marketable Securities$669.44M
Total Debt$126.23M
Net Cash-$543.20M
Net Cash Per Share-$17.97
Tangible Book Value Per Share$4.16
Margins
Gross margin is 31.12%, with operating margin of 21.19%, and net profit margin of 19.17%.
Gross Margin31.12%
Operating Margin21.19%
Pretax Margin22.57%
Net Profit Margin19.17%
EBITDA Margin21.19%
EBIT Margin21.19%
Analyst Forecast
The average price target for Medpace Holdings is $349.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$349.50
Price Target Upside17.39%
Analyst ConsensusModerate Buy
Analyst Count5
Revenue Growth Forecast11.84%
EPS Growth Forecast42.04%